English
Chinese
Cart
No Items In Cart
West - Home
We are a leading provider of innovative, high-quality injectable solutions and services committed to improving health for patients worldwide.
Our teams around the globe have been playing a vital role in the race to deliver an effective vaccine for COVID-19 working by the side of our customers to improve patient health.
With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.
As a trusted partner to established and emerging drug developers, we help ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients.
Integrated Solutions
Knowledge Center
Online Store
Announcements
A Landmark Collaboration that will Redefine the Future of Containment Solutions for Injectable Medicines
We are excited to announce our landmark collaboration with Corning Inc. This collaboration will enable new, advanced pharmaceutical packaging solutions.
OnDemand Webinar: Presented February 16, 2022
Unlocking the Mystery of Essential Performance Requirements for Combination Products
DeltaCube™ Modeling Platform
West’s DeltaCube™ Modeling Platform is an online, subscription-based modeling tool that provides customers with a data-driven approach to guide vial, stopper, and seal combination selection.
A Landmark Collaboration that will Redefine the Future of Containment Solutions for Injectable Medicines
We are excited to announce our landmark collaboration with Corning Inc. This collaboration will enable new, advanced pharmaceutical packaging solutions.
OnDemand Webinar: Presented February 16, 2022
Unlocking the Mystery of Essential Performance Requirements for Combination Products
DeltaCube™ Modeling Platform
West’s DeltaCube™ Modeling Platform is an online, subscription-based modeling tool that provides customers with a data-driven approach to guide vial, stopper, and seal combination selection.
Our Products
West products promote the efficiency, reliability and safety of the world's pharmaceutical drug supply.
Company Background
Our company is the leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world's top pharmaceutical and biotechnology companies–working by their side to improve patient health.
Our Culture of Giving
Nurturing a culture of philanthropy and community involvement is one of the defining characteristics of our company.
Careers
Come join a diverse, close-knit community of professionals, where everyone has a voice and opportunity to learn and grow through mutual trust and respect. Learn how you can join us and help us to create value for our customers and patients, our community, and our team members.
Featured Blogs
May 26, 2022
USP <382>: Think Systems; Not Components - Packaging/Delivery System Integrity and Needle Self-Sealing Capacity of Vial Systems
General chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems is slated to become official on December 1, 2025. This allows five years from the date of publication in December of 2020 for stakeholders to implement the new testing requirements for full compliance. While that date seems to be far off in the future, there has been interest in early adoption of the new chapter and implementation of the various tests it requires.
May 20, 2022
USP <382>: Think Systems, Not Components - Fragmentation, Penetration and Sealability of Vial Systems
United States Pharmacopeia (USP) requirements for elastomeric components of container closure systems used for parenteral products are changing. The original USP chapter for elastomeric components used in injectable drug packaging was <381> Elastomeric Components in Injectable Pharmaceutical Production Packaging/Delivery Systems. This addressed characterizing for biological reactivity, physicochemical testing and functionality testing and compliance was typically a supplier responsibility. The new chapter, USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems, will become effective on December 1, 2025. This will update the functionality tests for elastomers, whereas the functionality testing portion of USP <381> will be omitted. Under the new chapter, it will be the drug manufacturer’s responsibility to meet the functionality requirements on the final system.
May 26, 2022
USP <382>: Think Systems; Not Components - Packaging/Delivery System Integrity and Needle Self-Sealing Capacity of Vial Systems
General chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems is slated to become official on December 1, 2025. This allows five years from the date of publication in December of 2020 for stakeholders to implement the new testing requirements for full compliance. While that date seems to be far off in the future, there has been interest in early adoption of the new chapter and implementation of the various tests it requires.
May 20, 2022
USP <382>: Think Systems, Not Components - Fragmentation, Penetration and Sealability of Vial Systems
United States Pharmacopeia (USP) requirements for elastomeric components of container closure systems used for parenteral products are changing. The original USP chapter for elastomeric components used in injectable drug packaging was <381> Elastomeric Components in Injectable Pharmaceutical Production Packaging/Delivery Systems. This addressed characterizing for biological reactivity, physicochemical testing and functionality testing and compliance was typically a supplier responsibility. The new chapter, USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems, will become effective on December 1, 2025. This will update the functionality tests for elastomers, whereas the functionality testing portion of USP <381> will be omitted. Under the new chapter, it will be the drug manufacturer’s responsibility to meet the functionality requirements on the final system.